• Optimi Health set a discretionary equity line of credit to sell up to USD 100 million of common shares to Seven Knots.
• Draws priced at 97% of the lower of the day’s low trade or the period VWAP, capped at USD 2 million.
• Facility includes a USD 1.5 million unsecured, non-interest-bearing convertible promissory note, with a potential additional USD 500,000 note.
• Notes convert at 95% of the 20-day VWAP, subject to a USD 3 floor; maturities set at 24 months.
• Sales require an effective Form F-1 resale registration statement; ownership caps set at 4.99% for ELOC shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Optimi Health Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608141655PRIMZONEFULLFEED9810588) on August 14, 2026, and is solely responsible for the information contained therein.